FIELD: medicine.
SUBSTANCE: vaccine is high molecular weight protein conjugate with angiotensine II taken in high molecular weight protein : angiotensine II proportion of 1:12-55 in % by weight. The conjugate is modified with equilibrium quantity of immunocompetent polyelectrolyte like polyoxydonium.
EFFECT: stable physiological response within prolonged period of 6-12 months.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SYNTHETIC IMMUNOGEN FOR THERAPY AND PROPHYLAXIS OF ADDICTION WITH NARCOTIC AND PSYCHOACTIVE SUBSTANCES | 2003 |
|
RU2236257C1 |
| METHOD OF PREPARING OF VACCINE AGAINST CHOLERA | 1991 |
|
RU2021816C1 |
| VACCINE FOR HELMINTHIASIS CONTROL | 1996 |
|
RU2095082C1 |
| BACTERIAL VACCINE AND METHODS FOR PRODUCTION THEREOF | 2014 |
|
RU2684615C2 |
| SYNTHETIC IMMUNOGEN FOR PROTECTION AGAINST TOXIC ACTION OF NARCOTIC AND PSYCHOACTIVE SUBSTANCES | 2012 |
|
RU2526807C2 |
| POLYVALENT ASSOCIATED DIPHTHERIA, TETANUS TOXOIDS AND PERTUSSIS POLIOVIRUS VACCINES | 1997 |
|
RU2194531C2 |
| VACCINE AGAINST INFLUENZA VIRUS AND METHOD OF ITS PREPARING | 2000 |
|
RU2164148C1 |
| CONJUGATE OF ANGIOTENSIN PEPTIDE COMPONENT WITH CARRIER, VACCINE COMPOSITION, METHOD OF ANIMAL IMMUNISATION AND METHOD OF TREATMENT OR PREVENTION OF PHYSICAL DISORDER RELATED TO ANGIOTENSIN SYSTEM ACTIVATED BY RENIN | 2002 |
|
RU2350622C2 |
| MENINGOCOCCAL CONJUGATE VACCINATION | 2005 |
|
RU2379052C2 |
| VACCINATION WITH MENINGOCOCCAL COJUGATES | 2006 |
|
RU2429011C2 |
